A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/1998
11/04/1998	EP0874844A1 Use of heteroaromatic and tricyclic 1,4-dihydro-1,4-dioxo-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
11/04/1998	EP0874843A1 Novel substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases
11/04/1998	EP0874841A1 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor b2 antagonists
11/04/1998	EP0874830A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
11/04/1998	EP0874824A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998	EP0874823A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998	EP0874819A1 Imides as pde iii, pde iv and tnf inhibitors
11/04/1998	EP0874815A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof
11/04/1998	EP0874808A1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases
11/04/1998	EP0874805A1 Phenylacetamide derivatives
11/04/1998	EP0874800A1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity
11/04/1998	EP0874639A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
11/04/1998	EP0874621A1 Pharmaceutical compositions
11/04/1998	CN1197665A Ointment 'Yantongping' for relieving inflammatory pain and its preparation
11/03/1998	US5830994 Peptide derivatives of alpha-MSH and their application
11/03/1998	US5830915 Oral diseases; skin disorders; antiinflammatory agents
11/03/1998	US5830906 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
11/03/1998	US5830892 Piperidine and morphonline derivatives and their use as therapeutic agents
11/03/1998	US5830882 Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
11/03/1998	US5830705 Procaryotic or eukaryotic exoression of an exogenous dna sequence
11/03/1998	US5830671 Method for assaying for modulators of cytokines of the TFG β superfamily
11/03/1998	US5830660 Tumorigenesis protein
11/03/1998	US5830463 Yeast-based delivery vehicles
11/03/1998	US5830453 Use of IL-13 to induce 15-lipoxygenase
11/03/1998	CA1340112C Supression of cell proliferation by decorin
10/1998
10/29/1998	WO1998048024A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
10/29/1998	WO1998048017A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
10/29/1998	WO1998048016A1 Edg-1-like receptor
10/29/1998	WO1998047892A1 Substituted imidazoles useful in the treatment of inflammatory diseases
10/29/1998	WO1998047890A1 Substituted benzopyran derivatives for the treatment of inflammation
10/29/1998	WO1998047879A1 Substituted phenyl derivatives, their preparation and use
10/29/1998	WO1998047871A1 Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
10/29/1998	WO1998047861A1 Retinoid-like compounds
10/29/1998	WO1998047854A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998	WO1998047534A1 Stabilized medicaments containing cysteinyl derivatives
10/29/1998	WO1998047529A1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
10/29/1998	WO1998047511A1 Use of mizolastine for preparing a medicine for treating inflammation
10/29/1998	WO1998047509A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
10/29/1998	WO1998047502A1 IBUPROFEN THIOESTERS AS INHIBITORS OF Nf-λB-DEPENDENT PAIN AND INFLAMMATION MEDIATOR FORMATION
10/29/1998	WO1998047501A1 Pharmaceutical preparation containing nimesulide for oral administration
10/29/1998	WO1998039426A3 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
10/29/1998	WO1998030696A3 Secreted proteins and polynucleotides encoding them
10/29/1998	CA2297176A1 Substituted imidazoles useful in the treatment of inflammatory diseases
10/29/1998	CA2287501A1 Ibuprofen thioesters as inhibitors of nf-kb-dependent pain and inflammation mediator formation
10/29/1998	CA2286933A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
10/29/1998	CA2286865A1 Edg-1-like receptor
10/29/1998	CA2286681A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998	CA2286673A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
10/29/1998	CA2286252A1 Retinoid-like compounds
10/29/1998	CA2285424A1 Substituted phenyl derivatives, their preparation and use
10/28/1998	EP0874050A2 Integrin ligand ITGL-TSP
10/28/1998	EP0873362A1 PROCESS FOR ISOLATING IgG AND IgA
10/28/1998	EP0873351A1 Novel steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
10/28/1998	EP0873340A1 Heterocyclic substituted cyclopentane compounds
10/28/1998	EP0873338A1 Quinoline derivatives as type iv phosphodiesterase inhibitors
10/28/1998	EP0873331A1 Benzofuran carboxamides and sulphonamides
10/28/1998	EP0873330A1 Diarylalkenylamine derivatives
10/28/1998	EP0873315A1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives
10/28/1998	EP0873312A1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors
10/28/1998	EP0873310A1 Diphenyl pyridyl ethane derivatives as pde iv inhibitors
10/28/1998	EP0873304A1 Metalloproteinase inhibitors
10/28/1998	EP0873301A1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity
10/28/1998	EP0873295A1 Dimer-selective rxr modulators and methods for their use
10/28/1998	EP0873116A1 Anti-inflammatory and infection protective effects of sesamin-based lignans
10/28/1998	EP0873050A1 Pharmaceutical compositions for prevention and treatment of ulcerative colitis
10/28/1998	EP0701565B1 New prednisolone derivates
10/28/1998	EP0649418B1 7-(2-aminoethyl)-benzothiazolones
10/28/1998	CN1197450A Esters and amides as PLA2 inhibitors
10/28/1998	CN1197077A Nucleic acid construct for cell cycle regulated expression of structural genes
10/28/1998	CN1197059A Substituted amino compounds and their use as substances having analgesic effect
10/28/1998	CN1040440C Process for preparing dehydrocycloclausenamide derivatives
10/27/1998	US5827890 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
10/27/1998	US5827881 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity
10/27/1998	US5827874 Rheumatic, nonrheumatic and postoperative posttraumatic pain
10/27/1998	US5827869 Substituted biphenyl isoxazole sulfonamides
10/27/1998	US5827856 Method of treating insulin resistance
10/27/1998	US5827849 Cyclic dericatives, pharmaceutical compositions containing these compounds and processes for preparing them
10/27/1998	US5827834 Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease
10/27/1998	CA2102179C Quinuclidine derivatives
10/24/1998	CA2228743A1 Novel integrin ligand itgl-tsp
10/22/1998	WO1998046731A1 Inhibitors for urokinase receptor
10/22/1998	WO1998046644A1 Novel protein and process for producing the same
10/22/1998	WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA
10/22/1998	WO1998046633A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
10/22/1998	WO1998046632A2 Inhibitors for urokinase receptor
10/22/1998	WO1998046611A1 Compounds
10/22/1998	WO1998046604A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
10/22/1998	WO1998046603A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998	WO1998046582A1 Protease inhibitors
10/22/1998	WO1998046563A1 Metalloproteinase inhibitors
10/22/1998	WO1998046270A2 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998	WO1998046264A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998	WO1998046253A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
10/22/1998	WO1998046235A1 Analgesic combination
10/22/1998	DE19716713A1 Arzneimittel, enthaltend Ibuprofenthioester als Hemmer der Nf-kappaB abhängigen Bildung von Mediatoren von Entzündung und Schmerz A drug containing Ibuprofenthioester dependent as inhibitors of Nf-kappaB formation of mediators of inflammation and pain
10/22/1998	DE19715594A1 Analgetika-Kombination Analgesic combination
10/22/1998	CA2781623A1 Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
10/22/1998	CA2289476A1 Modified tnf.alpha. molecules, dna encoding such modified tnf.alpha. molecules and vaccines comprising such modified tnf.alpha. molecules and dna
10/22/1998	CA2287465A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998	CA2286791A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis

1 ... 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 ... 1272